Medical Automation Market Size, Share & Industry Analysis By Solution (Automated Devices {Robotic Surgical Systems, Robotic Rehabilitation Systems, Automated Drug Delivery & Infusion Systems, Automated Imaging & Diagnostic Systems, and Others}, Software & Workflow Automation {Clinical Workflow Automation, Automation, and Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2026-2034

The global medical automation market is witnessing significant growth due to advancements in automated solutions, including automated devices, workflow automation, laboratory automation, and others. Moreover, healthcare facilities are integrating automated solutions to enhance the clinical workflow in the market.

Medical Automation Market Driver

Increasing Need to Reduce Healthcare Workforce Burden to Propel the Market Growth

In recent years, the global healthcare sector has faced severe workforce shortages, resulting in increased medical errors. This is increasing pressure for the adoption of medical automation solutions. As a result, hospitals are currently adopting automated systems for diagnostics, medication dispensing, patient monitoring, and administrative tasks to maintain care quality with fewer staff. Such a scenario is anticipated to drive the market growth.

• For instance, according to an article published by Novel Medicare Solutions Pvt Ltd in May 2025, automation is transforming hospital care by streamlining everything from appointment scheduling and diagnostics to remote monitoring and robotic surgery support.

Download Free sample to learn more about this report.

According to data published by the Ambulatory Surgery Centers Association in March 2025, there were more than 6,500 ASCs in the U.S. in 2025. Similarly, according to the American Hospital Association (AHA) Hospital Statistics, 2025, there were 6,093 hospitals in the U.S.

Medical Automation Market Restraint

High Capital Investment and Integration Complexity to Hinder the Market Growth

Despite the increasing demand for automation, the high cost and integration challenges associated with medical automation are expected to restrain the market growth. These platforms require substantial upfront investment, infrastructure upgrades, and ongoing maintenance. This is hindering the adoption of automated solutions in hospitals with limited budgets, particularly in developing countries. Additionally, the technically complex integration of new automation systems with legacy electronic health records (EHRs), laboratory information systems (LISs), and pharmacy management software is also expected to hinder market growth.

Medical Automation Market Opportunity

Expansion of AI-Driven Automation for Diagnostics and Predictive Care to Offer Lucrative Growth Opportunity

In recent years, there has been the growing adoption of artificial intelligence, machine learning, and predictive analytics in the healthcare sector, as it can streamline diagnostic, radiology, and pathology workflows, thereby enhancing clinical decision support. This presents a significant opportunity for key players to expand their offerings and enter partnership agreements to expand the reach of their solutions in the near future.

• For instance, in March 2025, NVIDIA announced a partnership with GE HealthCare to drive innovation in autonomous imaging, concentrating on the development of autonomous X-ray and ultrasound technologies.

Segmentation

Key Insights

The report covers the following key insights:

• Advancements in AI & Robotics
• Key Industry Developments - (Mergers, Acquisitions & Partnerships, and Others)
• New Product Launches, by Key Players

Analysis by Solution

Based on solution, the market is subdivided into automated devices {robotic surgical systems, robotic rehabilitation systems, automated drug delivery & infusion systems, automated imaging & diagnostic systems, and others}, software & workflow automation {clinical workflow automation, administrative automation, AI-enabled diagnostic automation, and others}, laboratory automation systems {sample preparation automation, automated analyzers & integrated lab systems, microbiology automation systems, and others}, service automation {hospital logistics automation, supply chain & inventory automation, and others}, and others.

The automated devices segment is expected to account for the largest market share during the forecast period. The growth is attributed to a rapid shift toward robot-assisted orthopedic, gynecological, and general surgeries as automated devices increase precision and help healthcare facilities address staffing shortages.

• For instance, according to the data from the National Center for Biotechnology Information (NCBI) in November 2022, there is an annual increase of 15.0% in robotic surgeries across various specialties.

Analysis by Application

The market is divided into diagnostics, therapeutics, patient monitoring & management, pharmacy automation, and others by application.

The diagnostics segment is expected to hold a major share during the projection period. The growth is attributed to the increasing prevalence of chronic and infectious diseases, which drives the need for high testing volumes, involving the use of automated analyzers, AI-based radiology tools, and pathology solutions.

• For instance, according to data from the World Health Organization (WHO), around 40.8 million people were living with HIV worldwide at the end of 2024.

Analysis by End-user

By end-user, the market is subdivided into hospitals & clinics, diagnostic laboratories, pharmaceutical & biotechnology companies, and others.

The hospitals & clinics segment held the largest market share in 2025. The segment growth is due to the large number of surgical and diagnostic procedures performed in these settings, which makes them the primary users of automated solutions. This is attracting key players to expand the agreements with hospitals & clinics for automated solutions.

Regional Analysis

Request for Customization   to gain extensive market insights.

On the basis of region, the market has been studied across North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America.

North America held the largest global medical automation market share in 2025. The growth is attributed to high spending on new developments for automation, which is expected to lead to the introduction of new solutions. Moreover, the presence of established market players with growth initiatives such as new launches, collaborations, and partnerships is increasing the penetration of automated solutions in the region.

• For instance, in October 2025, Johnson & Johnson Services, Inc., announced the development of the MONARCH Platform for Urology, designed for robotic-assisted urologic procedures. This will be made commercially available in the U.S. in 2026.

Asia Pacific is expected to grow at the highest CAGR over the forecast period. The growth is attributed to the increasing clinical research activities and the expansion of the pharmaceutical sector in the region, which drives the need for automated workflow solutions to enhance accuracy and precision as well as address the limitations faced by professionals.

Key Players Covered

The global medical automation market is fragmented, with key companies focusing on new advancements in automation and increasing partnership agreements to accelerate the development of their solutions, which is expected to enhance their market share over the upcoming years.

The report includes the profiles of the following key players:

• Siemens Healthineers AG (Germany)
• Hoffmann-La Roche Ltd (Switzerland)
• BD (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Abbott (U.S.)
• GE Healthcare (U.S.)
• Intuitive Surgical Operations, Inc. (U.S.)
• Medtronic (Ireland)
• Omnicell (U.S.)
• Terumo Corporation (Japan)

Key Industry Developments

• September 2025: HMI Medical launched Japan’s Hinotori robotic-assisted surgical system in Malaysia, with installations at Mahkota Medical Centre and Regency Specialist Hospital.
• March 2024: Intuitive Surgical Operations, Inc. received FDA 510(k) clearance for its fifth-generation multiport robotic system, da Vinci 5, featuring over 150 enhancements, including improved accuracy, advanced 3D imaging, and next-gen force-sensing technology.